Experimental results published in the peer-reviewed journal Nature Communications prove TAE’s streamlined approach to form and optimize plasma in its Norm machine increases efficiency, significantly reduces complexity and cost, and accelerates the company’s path to net energy and commercial fusion power.
Oxy Low Carbon Ventures (OLCV) and TAE Technologies signed a memorandum to explore using TAE’s fusion technology for emissions-free power and heat in Direct Air Capture (DAC) facilities. The partnership aims to integrate fusion energy with Occidental’s clean energy sources for DAC operations.
Earning the BioTech Breakthrough Award for Oncology Innovation of the Year validates the progress TAE Life Sciences has made in readying its Alphabeam BNCT system for clinical trials worldwide
North Carolina has enacted landmark energy legislation that recognizes fusion technology’s safety and environmental benefits. Senate Bill 678 demonstrates the state’s commitment to investing in fusion as a new clean electricity source that can be an important part of the state’s energy mix.
Assembly Bill 1172 supports California’s fusion energy industry by recognizing this cutting-edge technology’s safety and environmental benefits while setting the stage for the state’s future regulatory framework.
TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy (BNCT) for cancer treatment, is thrilled to announce it is bringing BNCT to this year’s annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.